0001209191-16-157109.txt : 20161230 0001209191-16-157109.hdr.sgml : 20161230 20161230172229 ACCESSION NUMBER: 0001209191-16-157109 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140219 FILED AS OF DATE: 20161230 DATE AS OF CHANGE: 20161230 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Conatus Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001383701 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203183915 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16745 WEST BERNARDO DRIVE STREET 2: Suite 200 CITY: San Diego STATE: CA ZIP: 92127 BUSINESS PHONE: (858) 376-2600 MAIL ADDRESS: STREET 1: 16745 WEST BERNARDO DRIVE STREET 2: Suite 200 CITY: San Diego STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc DATE OF NAME CHANGE: 20061214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KISNER DANIEL L CENTRAL INDEX KEY: 0001073407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36003 FILM NUMBER: 162078050 MAIL ADDRESS: STREET 1: 2292 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2014-02-19 2014-02-25 0 0001383701 Conatus Pharmaceuticals Inc. CNAT 0001073407 KISNER DANIEL L C/O CONATUS PHARMACEUTICALS INC. 16745 WEST BERNARDO DRIVE, SUITE 200 SAN DIEGO CA 92127 1 0 0 0 Common Stock 2014-02-19 4 J 0 3145 0.00 A 3145 I See footnote Represents a pro rata distribution of 2,137 shares from Aberdare Partners III, L.P., of which the Reporting Person is a limited partner, and a pro rata distribution of 1,008 shares from Aberdare GP III, L.L.C., of which the Reporting Person is a non-managing member. Held by family trust of which the Reporting Person is a trustee. This Form 4/A amends the Form 4 filing made on behalf of the Reporting Person on February 25, 2014. The Form 4, as originally filed, incorrectly reported the ownership form as direct in Table I, Column 6. The amount of securities beneficially owned in Table I, Column 5 in the Form 4 filing made on behalf of the Reporting Person on April 10, 2015 incorrectly included the 3,145 shares of common stock acquired on February 19, 2014 as held in direct ownership form. /s/ Charles J. Cashion, as Attorney-in-Fact for Daniel L. Kisner 2016-12-30